Word

HYPERSTEALTH

Status

Pending

Status Code

732

Status Date

Wednesday, March 13, 2024

Serial Number

90696222

Mark Type

4000

Filing Date

Friday, May 7, 2021

Published for Opposition

Tuesday, August 9, 2022

Trademark Owner History

Generate Biomedicines, Inc. - Owner At Publication

Classifications

9 Downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development

5 Pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic pharmaceuticals for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy

1 Biological and chemical agents for scientific and research use

42 Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; Providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products

HYPER STEALTH

Trademark Events

Mar 14, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 13, 2024

Sou Extension 3 Granted

Mar 13, 2024

Sou Extension 3 Filed

Mar 13, 2024

Sou Teas Extension Received

Sep 19, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 15, 2023

Sou Extension 2 Granted

Sep 15, 2023

Sou Extension 2 Filed

Sep 15, 2023

Sou Teas Extension Received

Apr 1, 2023

Notice Of Approval Of Extension Request E-Mailed

Mar 30, 2023

Sou Extension 1 Granted

Mar 30, 2023

Sou Extension 1 Filed

Mar 30, 2023

Sou Teas Extension Received

Nov 22, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 22, 2022

Teas Change Of Correspondence Received

Nov 22, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 22, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 22, 2022

Teas Change Of Owner Address Received

Oct 4, 2022

Noa E-Mailed - Sou Required From Applicant

Aug 9, 2022

Official Gazette Publication Confirmation E-Mailed

Aug 9, 2022

Published For Opposition

Jul 20, 2022

Notification Of Notice Of Publication E-Mailed

Jul 5, 2022

Approved For Pub - Principal Register

Jul 5, 2022

Examiner's Amendment Entered

Jul 5, 2022

Notification Of Examiners Amendment E-Mailed

Jul 5, 2022

Examiners Amendment E-Mailed

Jul 5, 2022

Examiners Amendment -Written

Jul 1, 2022

Teas/Email Correspondence Entered

Jul 1, 2022

Correspondence Received In Law Office

Jul 1, 2022

Teas Response To Office Action Received

Jan 12, 2022

Notification Of Non-Final Action E-Mailed

Jan 12, 2022

Non-Final Action E-Mailed

Jan 12, 2022

Non-Final Action Written

Jan 12, 2022

Assigned To Examiner

Aug 9, 2021

New Application Office Supplied Data Entered